Abstract:OBJECTIVE To construct a novel biomimetic calcium phosphate (BioCaP) scaffold loaded with bone morphogenetic protein-2 (BMP-2), and to investigate its role in the osteogenesis of human adipose-derived stem cells (hASCs) in vitro and in vivo. METHODS The BioCaP scaffold coprecipitated with BMP-2 (BMP-2-BioCaP) was constructed in this study. Field emission scanning electron microscopy (SEM) was used to analyze the morphology of the surfaces. The release kinetics was measured to evaluate the slow-release characteristics in vitro. BMP-2-BioCaP was immersed in proliferation medium (PM) or osteogenic medium (OM), respectively. The supernatants were collected and used to culture hASCs in vitro. Cell numbers were determined using the cell-counting kit-8 (CCK-8) to assess the cell proliferation. After 7 and 14 days, alkaline phosphatase (ALP) staining and quantification were performed to test the activity of ALP. After 14 and 21 days, the calcification deposition was determined by alizarin red S (ARS) staining and quantification. The expressions of the osteoblast-related genes were tested on day 4 and day 14. In the in vivo study, 6 nude mice were used and implanted subcutaneously into the back of the nude mice for 4 groups: (1) BioCaP scaffold only, (2) BioCaP scaffold+hASCs, (3) BMP-2-BioCaP scaffold, (4) BMP-2-BioCaP scaffold+hASCs (test group). After 4 weeks of implantation, hematoxylin-eosin (HE) staining was performed to evaluate the in vivo osteogenesis of hASCs. RESULTS SEM observations showed that BioCaP and BMP-2-BioCaP scaffold were entirely composed of straight, plate-like and sharp-edged crystal units, and the length of the crystal units varied between 5 and 10 μm. Release kinetics analysis demonstrated that BMP-2 incorporated with BioCaP could be released at certain concentration and last for more than 21 days, and the accumulative protein release could reach 20%. CCK-8 assays showed that cell proliferation was not significantly affected by BMP-2-BioCaP. ALP activity was higher by the induction of OM+BMP-2-BioCaP than of the other groups (P<0.01). More mineralization deposition and more expressions of osteoblast-related genes such as Runt-related transcription factor 2 (RUNX2), ALP, osteopontin (OPN) and osteocalcin (OC) were determined in the OM+BMP-2-BioCaP group at different time points (P<0.01). HE staining showed that, in the test group and BMP-2-BioCaP scaffold group, the extracellular matrix (ECM) with eosinophilic staining were observed around hASCs, and newly-formed bone-like tissues could be found in ECM around the scaffold materials. Moreover, compared with the BMP-2-BioCaP scaffold group, more bone-like tissues could be observed in ECM with typical structure of bone tissue in the test groups. No obvious positive results were found in the other groups. CONCLUSION BMP-2-BioCaP scaffold could achieve slow-release of BMP-2 and promote the osteogenic differentiation of hASCs in vitro and in vivo. The novel tissue-engineered bone composed of hASCs and BMP-2-BioCaPis promising for the repair of bone defect.

[Preparation of a Biphasic Calcined Bone of Beta-Tcp/hap and Its Application in BMP-2 Gene Medicine].

Evaluation of Bone Regeneration by Β Tricalcium Phosphate/Collagen Scaffold Loaded with Bone Morphogenetic Proteins 2 Plasmid in Rat Cranial Defect

BMP2-mimicking Peptide Modified with E7 Coupling to Calcined Bovine Bone Enhanced Bone Regeneration Associating with Activation of the Runx2/SP7 Signaling Axis.

A new bone-inducing biodegradable porous beta-tricalcium phosphate

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

Bone Response to the Multilayer BMP-2 Gene Coated Porous Titanium Implant Surface.

Influence of Multilayer Rhbmp-2 DNA Coating on the Proliferation and Differentiation of MC3T3-E1 Cells Seeded on Roughed Titanium Surface.

Ectopic Osteogenesis of Hbmp-2 Gene-Transduced Human Bone Mesenchymal Stem Cells/bcb

Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.

[Osteogenic Potential of Three Kinds of Calcium Phosphate Ceramics As Carriers for Recombinant Human Morphogenetic Protein-2 in Vivo].

Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2

Tissue-engineered Bone Formation Using Human Bone Marrow Stromal Cells and Novel Β-Tricalcium Phosphate

[A Novel Tissue-Engineered Bone Constructed by Using Human Adipose-Derived Stem Cells and Biomimetic Calcium Phosphate Scaffold Coprecipitated with Bone Morphogenetic Protein-2].

[Experimental Studies on the Porous Calcium Phosphate Cement Combined with Recombinant Human Bone Morphogenetic Protein 2 for Bone Defects Repair].

Preparation and Osteogenic Activity of Combining Calcium Phosphate Cement with Bone Morphogenetic Protein Composite As a Bone Graft Material

Human Bone Marrow Derived Mesenchymal Stem Cells Combined with Porous Beta-tricalcium Phosphate Promote Bone Formation in vivo

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres

[EXPERIMENTAL STUDY ON TISSUE ENGINEERED BONES CONSTRUCTED BY HUMAN BONE MORPHOGENETIC PROTEIN 2 GENE-MODIFIED HUMAN BONE MARROW MESENCHYMAL STEM CELLS].

HA/β-TCP Biphasic Calcium Phosphate Ceramics Derived From Butterfish Bones Loaded With Bone Marrow Mesenchymal Stem Cells Promote Osteogenesis

Rhbmp-2-Loaded Calcium Silicate/Calcium Phosphate Cement Scaffold with Hierarchically Porous Structure for Enhanced Bone Tissue Regeneration